Association of Cannabis Use Reduction With Improved Functional Outcomes: An Exploratory Aggregated Analysis From Seven Cannabis Use Disorder Treatment Trials to Extract Data-Driven Cannabis Reduction Metrics
Reductions in cannabis use (∼50% reduction in use days and ∼75% reduction in use amounts) were associated with clinician-assessed improvement, which suggests that cannabis use reduction may yield benefit among individuals with cannabis use disorder. These exploratory results extract a data-driven metric to inform future studies, clinicians, patients, and policy recommendations.
Authors
- Rachel L. Tomko (ORCID: https://orcid.org/0000-0002-6961-4399)
- Erin A. McClure (ORCID: https://orcid.org/0000-0001-9744-7818)
- Brian Neelon (ORCID: https://orcid.org/0000-0002-8929-6033)
- Aimee L. McRae‐Clark (ORCID: https://orcid.org/0000-0002-9774-318X)
- Nathaniel L. Baker (ORCID: https://orcid.org/0000-0003-3313-1579)
- Kevin M. Gray (ORCID: https://orcid.org/0000-0003-4503-7395)
Institutions
- Ralph H. Johnson VA Medical Center (US)
Publication Details
- Journal
- American Journal of Psychiatry
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1176/appi.ajp.20230508
- Citations
- 9
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 4.03
Funders
- Medical University of South Carolina